Cargando…

Heart rate variability is differentially altered in multiple sclerosis: implications for acute, worsening and progressive disability

BACKGROUND: Sympathovagal imbalance has been associated with poor prognosis in chronic diseases, but there is conflicting evidence in multiple sclerosis. OBJECTIVES: The objective of this study was to investigate the autonomic nervous system dysfunction correlation with inflammation and progression...

Descripción completa

Detalles Bibliográficos
Autores principales:	Studer, Valeria, Rocchi, Camilla, Motta, Caterina, Lauretti, Benedetta, Perugini, Jacopo, Brambilla, Laura, Pareja-Gutierrez, Lorena, Camera, Giorgia, Barbieri, Francesca Romana, Marfia, Girolama A, Centonze, Diego, Rossi, Silvia
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	SAGE Publications 2017
Materias:	Original Research Paper
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5408506/ https://www.ncbi.nlm.nih.gov/pubmed/28607756 http://dx.doi.org/10.1177/2055217317701317

Ejemplares similares

Disability and Fatigue Can Be Objectively Measured in Multiple Sclerosis
por: Motta, Caterina, et al.
Publicado: (2016)

Quantification of postural stability in minimally disabled multiple sclerosis patients by means of dynamic posturography: an observational study
por: Grassi, Lucia, et al.
Publicado: (2017)

Association between Early Neuroretinal Dysfunction and Peripheral Motor Unit Loss in Patients with Type 1 Diabetes Mellitus
por: Picconi, Fabiana, et al.
Publicado: (2018)

Assessment of Macular Function by Multifocal Electroretinogram in Patients with Multiple Sclerosis Treated with Fingolimod
por: Barbano, Lucilla, et al.
Publicado: (2021)

Multifocal Electroretinogram Photopic Negative Response: A Reliable Paradigm to Detect Localized Retinal Ganglion Cells’ Impairment in Retrobulbar Optic Neuritis Due to Multiple Sclerosis as a Model of Retinal Neurodegeneration
por: Barbano, Lucilla, et al.
Publicado: (2022)

Optimizing the “Time to pregnancy” in women with multiple sclerosis: the OPTIMUS Delphi survey
por: Carbone, Luigi, et al.
Publicado: (2023)

Bridging Therapies With Injectable Immunomodulatory Drugs in the Management of Multiple Sclerosis: A Delphi Survey of an Italian Expert Panel of Neurologists
por: Marfia, Girolama Alessandra, et al.
Publicado: (2022)

Topographical Correlation between Structural and Functional Impairment of the Macular Inner Retinal Layers in Multiple Sclerosis Eyes with a History of Optic Neuropathy
por: Parisi, Vincenzo, et al.
Publicado: (2023)

Predictors of disability worsening in clinically isolated syndrome
por: Jokubaitis, Vilija G, et al.
Publicado: (2015)

Remodeling Functional Connectivity in Multiple Sclerosis: A Challenging Therapeutic Approach
por: Stampanoni Bassi, Mario, et al.
Publicado: (2017)

Interleukin-1β causes excitotoxic neurodegeneration and multiple sclerosis disease progression by activating the apoptotic protein p53
por: Rossi, Silvia, et al.
Publicado: (2014)

Safety of Natalizumab infusion in multiple sclerosis patients during active SARS-CoV-2 infection
por: Landi, Doriana, et al.
Publicado: (2022)

Cerebrospinal fluid detection of interleukin-1β in phase of remission predicts disease progression in multiple sclerosis
por: Rossi, Silvia, et al.
Publicado: (2014)

IL-6 in the Cerebrospinal Fluid Signals Disease Activity in Multiple Sclerosis
por: Stampanoni Bassi, Mario, et al.
Publicado: (2020)

Functional Assessment of Outer and Middle Macular Layers in Multiple Sclerosis
por: Ziccardi, Lucia, et al.
Publicado: (2020)

Cortical fractal dimension predicts disability worsening in Multiple Sclerosis patients
por: Roura, Eloy, et al.
Publicado: (2021)

Platelet-derived growth factor predicts prolonged relapse-free period in multiple sclerosis
por: Stampanoni Bassi, Mario, et al.
Publicado: (2018)

Cerebrospinal fluid lactate is associated with multiple sclerosis disease progression
por: Albanese, Maria, et al.
Publicado: (2016)

Deep gray matter volume loss drives disability worsening in multiple sclerosis
por: Eshaghi, Arman, et al.
Publicado: (2018)

Gut microbiome composition is associated with long-term disability worsening in multiple sclerosis
por: Devolder, Lindsay, et al.
Publicado: (2023)

COVID-19 vaccine hesitancy among Italian people with multiple sclerosis
por: Proietti, Francesca, et al.
Publicado: (2022)

Overall Disability Response Score: An integrated endpoint to assess disability improvement and worsening over time in patients with multiple sclerosis
por: Chang, Ih, et al.
Publicado: (2022)

Influence of Previous Disease-Modifying Drug Exposure on T-Lymphocyte Dynamic in Patients With Multiple Sclerosis Treated With Ocrelizumab
por: Landi, Doriana, et al.
Publicado: (2022)

Interleukin-1β Alters Hebbian Synaptic Plasticity in Multiple Sclerosis
por: Stampanoni Bassi, Mario, et al.
Publicado: (2020)

Adherence to social distancing and use of personal protective equipment and the risk of SARS-CoV-2 infection in a cohort of patients with multiple sclerosis
por: Landi, Doriana, et al.
Publicado: (2020)

pRNFL as a marker of disability worsening in the medium/long term in patients with MS
por: Cordano, Christian, et al.
Publicado: (2018)

Long-Term Consequences of Worsened Poststroke Status in Patients With Premorbid Disability: Implications for Treatment
por: Ganesh, Aravind, et al.
Publicado: (2018)

Disability worsening among persons with multiple sclerosis and depression: A Swedish cohort study
por: Binzer, Stefanie, et al.
Publicado: (2019)

Patho- physiological role of BDNF in fibrin clotting
por: Amadio, Patrizia, et al.
Publicado: (2019)

Opposite Roles of NMDA Receptors in Relapsing and Primary Progressive Multiple Sclerosis
por: Rossi, Silvia, et al.
Publicado: (2013)

Predictors of lymphocyte count recovery after dimethyl fumarate-induced lymphopenia in people with multiple sclerosis
por: Lucchini, Matteo, et al.
Publicado: (2021)

Amyloid-β Homeostasis Bridges Inflammation, Synaptic Plasticity Deficits and Cognitive Dysfunction in Multiple Sclerosis
por: Stampanoni Bassi, Mario, et al.
Publicado: (2017)

Brain atrophy and disability worsening in primary progressive multiple sclerosis: insights from the INFORMS study
por: Miller, David H., et al.
Publicado: (2018)

Does a modifiable risk factor score predict disability worsening in people with multiple sclerosis?
por: Marck, Claudia H, et al.
Publicado: (2019)

A matter of atrophy: differential impact of brain and spine damage on disability worsening in multiple sclerosis
por: Ruggieri, Serena, et al.
Publicado: (2021)

Predicting disability progression and cognitive worsening in multiple sclerosis using patterns of grey matter volumes
por: Colato, Elisa, et al.
Publicado: (2021)

Occurrence and Severity of Coronavirus Disease 2019 Are Associated With Clinical Disability Worsening in Patients With Multiple Sclerosis
por: Peeters, Gertjan, et al.
Publicado: (2023)

Association between a Genetic Variant of Type-1 Cannabinoid Receptor and Inflammatory Neurodegeneration in Multiple Sclerosis
por: Rossi, Silvia, et al.
Publicado: (2013)

Complex Rearrangement of the Entire Retinal Posterior Pole in Patients with Relapsing Remitting Multiple Sclerosis
por: Martucci, Alessio, et al.
Publicado: (2021)

Transient Receptor Potential Vanilloid 1 Modulates Central Inflammation in Multiple Sclerosis
por: Stampanoni Bassi, Mario, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_n9bqa8v2ir9lm22q9554u74qug